Display options
Cite
Han C, Wang SM, Lee SJ, et al. Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Med J. 2015;51(2):66-80doi: 10.4068/cmj.2015.51.2.66.
Han, C., Wang, S. M., Lee, S. J., Jun, T. Y., & Pae, C. U. (2015). Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam medical journal, 51(2), 66-80. https://doi.org/10.4068/cmj.2015.51.2.66
Han, Changsu, et al. "Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice." Chonnam medical journal vol. 51,2 (2015): 66-80. doi: https://doi.org/10.4068/cmj.2015.51.2.66
Han C, Wang SM, Lee SJ, Jun TY, Pae CU. Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Med J. 2015 Aug;51(2):66-80. doi: 10.4068/cmj.2015.51.2.66. Epub 2015 Aug 17. PMID: 26306301; PMCID: PMC4543152.
Copy Download .nbib Format: NLM
Share it on

Chonnam Med J. 2015 Aug;51(2):66-80. doi: 10.4068/cmj.2015.51.2.66. Epub 2015 Aug 17.

Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice.

Chonnam medical journal

Changsu Han, Sheng-Min Wang, Soo-Jung Lee, Tae-Youn Jun, Chi-Un Pae

Affiliations

  1. Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea.
  2. International Health Care Center, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
  3. Department of Psychiatry, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Busan, Korea.
  4. Department of Psychiatry, St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
  5. Department of Psychiatry, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Busan, Korea. ; Department of Psychiatry and Behavioral Medicines, Duke University Medical Center, Durham, NC, USA.

PMID: 26306301 PMCID: PMC4543152 DOI: 10.4068/cmj.2015.51.2.66

Abstract

Major depressive disorder (MDD) is a recurrent, chronic, and devastating disorder leading to serious impairment in functional capacity as well as increasing public health care costs. In the previous decade, switching therapy and dose adjustment of ongoing antidepressants was the most frequently chosen subsequent treatment option for MDD. However, such recommendations were not based on firmly proven efficacy data from well-designed, placebo-controlled, randomized clinical trials (RCTs) but on practical grounds and clinical reasoning. Aripiprazole augmentation has been dramatically increasing in clinical practice owing to its unique action mechanisms as well as proven efficacy and safety from adequately powered and well-controlled RCTs. Despite the increased use of aripiprazole in depression, limited clinical information and knowledge interfere with proper and efficient use of aripiprazole augmentation for MDD. The objective of the present review was to enhance clinicians' current understanding of aripiprazole augmentation and how to optimize the use of this therapy in the treatment of MDD.

Keywords: Antidepressive agents; Aripiprazole; Depressive disorder, Major

References

  1. Am J Psychiatry. 2006 Jan;163(1):28-40 - PubMed
  2. Expert Opin Investig Drugs. 2015 Apr;24(4):445-53 - PubMed
  3. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):355-7 - PubMed
  4. Am J Psychiatry. 2015 Dec;172(12):1251-8 - PubMed
  5. Int J Psychiatry Clin Pract. 2013 Aug;17(3):160-9 - PubMed
  6. JAMA. 2003 Jun 18;289(23):3095-105 - PubMed
  7. Ann Clin Psychiatry. 2005 Jul-Sep;17(3):161-5 - PubMed
  8. Psychiatry Res. 2002 Oct 10;112(2):145-52 - PubMed
  9. J Ment Health Policy Econ. 2014 Dec;17(4):163-72 - PubMed
  10. Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S - PubMed
  11. Neuropsychiatr Dis Treat. 2015 Jan 27;11:225-32 - PubMed
  12. Br J Psychiatry. 1999 Jul;175:12-6 - PubMed
  13. Can J Psychiatry. 2011 Jun;56(6):317-23 - PubMed
  14. Psychopharmacology (Berl). 2002 May;161(2):143-51 - PubMed
  15. Postgrad Med. 2010 Jul;122(4):39-48 - PubMed
  16. Int Clin Psychopharmacol. 2013 Mar;28(2):87-90 - PubMed
  17. Can J Psychiatry. 2000 Jun;45(5):476-81 - PubMed
  18. Neuropsychiatr Dis Treat. 2011;7:303-12 - PubMed
  19. Acta Psychiatr Scand. 2001 Jan;103(1):66-72 - PubMed
  20. J Clin Psychopharmacol. 2011 Oct;31(5):563-8 - PubMed
  21. J Clin Psychiatry. 2007;68 Suppl 3:25-9 - PubMed
  22. World J Biol Psychiatry. 2002 Jan;3(1):5-43 - PubMed
  23. Psychiatry Investig. 2015 Jan;12(1):1-8 - PubMed
  24. CNS Drugs. 2013 May;27 Suppl 1:S39-45 - PubMed
  25. Am J Psychiatry. 2010 Mar;167(3):281-8 - PubMed
  26. J Affect Disord. 2014 Jun;162:20-5 - PubMed
  27. J Affect Disord. 2010 Dec;127(1-3):19-30 - PubMed
  28. Psychiatry Investig. 2014 Oct;11(4):371-9 - PubMed
  29. J Psychiatr Res. 2015 Jul-Aug;66-67:84-94 - PubMed
  30. Lancet. 2009 Feb 28;373(9665):746-58 - PubMed
  31. CNS Drugs. 2009 Aug;23(8):627-47 - PubMed
  32. World J Biol Psychiatry. 2011 Aug;12(5):364-75 - PubMed
  33. Prim Care Companion CNS Disord. 2012;14(6):null - PubMed
  34. CNS Spectr. 2009 Apr;14(4):197-206 - PubMed
  35. Am J Psychiatry. 2006 Nov;163(11):1905-17 - PubMed
  36. J Clin Psychiatry. 2007 Jun;68(6):843-53 - PubMed
  37. Int Clin Psychopharmacol. 2012 May;27(3):125-33 - PubMed
  38. J Clin Psychopharmacol. 2012 Feb;32(1):56-60 - PubMed
  39. J Affect Disord. 2002 Aug;70(3):313-7 - PubMed
  40. Psychol Med. 2014 Jul;44(10):2017-28 - PubMed
  41. Psychiatr Danub. 2011 Sep;23(3):302-7 - PubMed
  42. Psychother Psychosom. 2012;81(2):87-97 - PubMed
  43. Int Clin Psychopharmacol. 2008 May;23(3):113-9 - PubMed
  44. Int J Geriatr Psychiatry. 2011 Jun;26(6):564-72 - PubMed
  45. Drug Metab Dispos. 2007 Aug;35(8):1292-300 - PubMed
  46. CNS Neurosci Ther. 2012 Apr;18(4):359-60 - PubMed
  47. Psychopharmacol Bull. 2006;39(1):38-104 - PubMed
  48. Int Clin Psychopharmacol. 2014 Mar;29(2):116-9 - PubMed
  49. Pharmacopsychiatry. 2013 Mar;46(2):69-76 - PubMed
  50. J Psychiatr Res. 2014 Feb;49:75-82 - PubMed
  51. Am J Psychiatry. 2008 Mar;165(3):342-51 - PubMed
  52. Eur Neuropsychopharmacol. 2007 Jan;17(1):32-6 - PubMed
  53. Expert Opin Pharmacother. 2014 Mar;15(4):443-7 - PubMed
  54. Expert Rev Neurother. 2013 Jul;13(7):851-70 - PubMed
  55. Annu Rev Public Health. 2013;34:119-38 - PubMed
  56. Curr Opin Investig Drugs. 2009 Jan;10(1):75-90 - PubMed
  57. J Psychiatr Res. 2015 May;64:88-98 - PubMed
  58. J Clin Psychiatry. 2015 Apr;76(4):e531-3 - PubMed
  59. Arch Gen Psychiatry. 1988 Feb;45(2):129-37 - PubMed
  60. Expert Rev Neurother. 2011 Nov;11(11):1561-4 - PubMed
  61. Int Clin Psychopharmacol. 2013 Nov;28(6):322-9 - PubMed
  62. Psychiatry Investig. 2015 Apr;12(2):155-63 - PubMed
  63. J Affect Disord. 2010 Jan;120(1-3):133-40 - PubMed
  64. Ther Drug Monit. 1997 Apr;19(2):219-23 - PubMed
  65. Am J Geriatr Psychiatry. 2008 Jan;16(1):21-30 - PubMed
  66. J Clin Psychiatry. 2011 Mar;72(3):412-3 - PubMed
  67. Psychiatry Res. 2014 Mar 30;221(3):231-9 - PubMed
  68. Eur Neuropsychopharmacol. 2006 May;16(4):281-7 - PubMed
  69. J Clin Psychiatry. 2008 Dec;69(12):1928-36 - PubMed
  70. Expert Opin Pharmacother. 2009 Apr;10(5):875-87 - PubMed
  71. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1165-73 - PubMed
  72. J Psychiatr Pract. 2008 Jan;14 (1):34-44 - PubMed
  73. Expert Rev Neurother. 2012 Oct;12(10):1185-8 - PubMed
  74. Eur Psychiatry. 2009 Apr;24(3):164-70 - PubMed
  75. J Psychiatr Pract. 2014 May;20(3):178-87 - PubMed
  76. Am J Psychiatry. 2007 May;164(5):753-60 - PubMed
  77. Int J Neuropsychopharmacol. 2009 May;12(4):459-73 - PubMed
  78. Psychiatry Investig. 2014 Jul;11(3):281-9 - PubMed
  79. J Psychopharmacol. 2008 Jun;22(4):343-96 - PubMed
  80. Clin Ther. 2011 Sep;33(9):1246-57 - PubMed
  81. J Clin Psychiatry. 2012 Mar;73(3):353-7 - PubMed
  82. Am J Psychiatry. 2009 Sep;166(9):980-91 - PubMed
  83. J Clin Psychopharmacol. 2008 Apr;28(2):156-65 - PubMed
  84. Brain Res. 2002 Nov 15;955(1-2):264-7 - PubMed
  85. Neuropsychopharmacology. 2006 Nov;31(11):2505-13 - PubMed
  86. Psychiatry Investig. 2015 Apr;12(2):274-7 - PubMed
  87. Drugs. 2011 Jan 1;71(1):43-64 - PubMed
  88. Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45 - PubMed
  89. Psychiatry Investig. 2015 Apr;12(2):268-73 - PubMed
  90. Prim Care Companion J Clin Psychiatry. 2008;10(6):440-7 - PubMed
  91. Psychosomatics. 2011 Jul-Aug;52(4):395-7 - PubMed
  92. Psychiatry Investig. 2015 Apr;12(2):278-9 - PubMed
  93. Psychiatr Clin North Am. 2003 Jun;26(2):457-94, x - PubMed
  94. Biol Psychiatry. 2007 Dec 1;62(11):1217-27 - PubMed
  95. Clin Chem. 2002 Jul;48(7):983-8 - PubMed
  96. Expert Opin Pharmacother. 2011 Dec;12(18):2923-8 - PubMed
  97. J Clin Psychopharmacol. 2012 Feb;32(1):114-9 - PubMed
  98. Brain Res Mol Brain Res. 2005 Aug 18;138(2):228-35 - PubMed
  99. Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65 - PubMed
  100. CNS Drugs. 2008;22(5):367-88 - PubMed
  101. J Affect Disord. 2013 Dec;151(3):899-905 - PubMed
  102. Ann Pharmacother. 2011 Jan;45(1):95-100 - PubMed
  103. Int J Neuropsychopharmacol. 2010 Feb;13(1):15-30 - PubMed
  104. J Clin Psychopharmacol. 2009 Aug;29(4):362-7 - PubMed
  105. J Clin Psychiatry. 2007 Jul;68(7):1071-7 - PubMed
  106. Depress Anxiety. 2012 Jul;29(7):574-86 - PubMed
  107. J Clin Psychiatry. 2015 Apr;76(4):e487-98 - PubMed
  108. J Psychiatr Res. 2014 May;52:7-14 - PubMed
  109. Am J Psychiatry. 2011 Jul;168(7):689-701 - PubMed
  110. Med Hypotheses. 2013 Aug;81(2):183-5 - PubMed
  111. Biol Psychiatry. 2002 Jan 15;51(2):183-8 - PubMed
  112. Biol Psychiatry. 2008 Apr 1;63(7):699-704 - PubMed
  113. Depress Anxiety. 2007;24(7):522-6 - PubMed
  114. CNS Drugs. 2011 Feb;25(2):109-27 - PubMed
  115. CNS Drugs. 2013 May;27 Suppl 1:S53-7 - PubMed
  116. J Psychiatry Neurosci. 2015 May;40(3):174-86 - PubMed
  117. Depress Anxiety. 2010 Oct;27(10):964-76 - PubMed
  118. Am J Geriatr Psychiatry. 2011 Dec;19(12):989-97 - PubMed
  119. CNS Spectr. 2014 Dec;19(6):528-34 - PubMed
  120. Prim Care Companion CNS Disord. 2012;14(3):null - PubMed

Publication Types